Intuitive Surgical (ISRG) beat expectations in Q2 FY2026 on revenue of $2.9B versus the $2.8B estimate (+18.5% YoY) and EPS of $2.80. The next Intuitive Surgical (ISRG) earnings date is Oct 20, 2026. Below is the full Intuitive Surgical earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
$2.9B (vs $2.8B est · +2.4% surprise · +18.5% YoY)
EPS
$2.80 (vs $2.48 est · +12.9% surprise · +26.1% YoY)
Share price
$373.57 (-1.4%)
Market cap
$132.0B
Intuitive Surgical (ISRG) Earnings Analysis — beat / miss history
Quarter
Revenue
EPS
EPS surprise
Next-day move
Verdict
Q3 FY2026
$2.9B vs $2.8B est
$2.80 vs $2.48 est
+12.9%
-11.2%
Beat
Q2 FY2026
$2.8B vs $2.6B est
$2.80 vs $2.51 est
+11.6%
+3.9%
Beat
Q1 FY2026
$2.9B vs $2.8B est
$2.53 vs $2.27 est
+11.5%
+0.1%
Beat
Q4 FY2025
$2.5B vs $2.4B est
$2.40 vs $1.99 est
+20.6%
+15.0%
Beat
Q3 FY2025
$2.4B vs $2.4B est
$2.19 vs $1.93 est
+13.5%
-2.7%
Beat
Q2 FY2025
$2.3B vs $2.2B est
$1.81 vs $1.74 est
+4.0%
+4.2%
Beat
Q1 FY2025
$2.4B vs $2.2B est
$2.21 vs $1.76 est
+25.6%
-4.3%
Beat
Q4 FY2024
$2.0B vs $2.0B est
$1.84 vs $1.63 est
+12.9%
+9.3%
Mixed
Top institutional holders
Holder
% outstanding
Shares
Value
QoQ change
Blackrock, INC.
8.5%
30.0M
$11.9B
-0.2%
Vanguard Capital Management LLC
6.5%
23.1M
$9.2B
+0.2%
State Street Corp
4.5%
16.1M
$6.4B
+1.4%
Invesco Ltd.
3.3%
11.8M
$4.7B
+58.9%
Price T Rowe Associates INC /Md/
3.2%
11.3M
$4.5B
-10.1%
Geode Capital Management, LLC
2.4%
8.5M
$3.4B
+0.8%
Capital World Investors
2.2%
7.7M
$3.1B
-3.8%
Vanguard Portfolio Management LLC
2.0%
7.2M
$2.9B
+0.1%
Morgan Stanley
1.8%
6.6M
$2.6B
+8.3%
Norges Bank
1.4%
5.0M
$2.0B
+100.0%
Recent insider transactions
Insider
Role
Date
Type
Shares
Value
Brosius Mark
officer: EVP & Chief Mfg and Supply Cha
2026-08-20
Sell
77
$30520
Brosius Mark
officer: EVP & Chief Mfg and Supply Cha
2026-08-21
Sell
77
$28919
Brosius Mark
officer: EVP & Chief Mfg and Supply Cha
2026-08-17
Sell
77
$30082
Brosius Mark
officer: EVP & Chief Mfg and Supply Cha
2026-08-18
Sell
77
$30338
Brosius Mark
officer: EVP & Chief Mfg and Supply Cha
2026-08-19
Sell
77
$30358
GUTHART GARY S
director
2026-08-11
Sell
10K
$4.0M
Ladd Amy L
director
2026-08-10
Sell
400
$151600
Ladd Amy L
director
2026-08-11
Sell
72
$28303
What you'll find
Next Intuitive Surgical (ISRG) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment Intuitive Surgical reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in Intuitive Surgical (ISRG)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is Intuitive Surgical's next earnings date?
Intuitive Surgical's (ISRG) next scheduled earnings date is Oct 20, 2026. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Intuitive Surgical (ISRG) beat or miss earnings?
In Q2 FY2026, Intuitive Surgical (ISRG) posted beat results — revenue of $2.9B versus the $2.8B estimate (+2.4% surprise) and EPS of $2.80 versus $2.48 expected (+12.9% surprise). Magnisto decodes every Intuitive Surgical (ISRG) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
How often does Intuitive Surgical beat earnings estimates?
Over its last 8 reported quarters, Intuitive Surgical (ISRG) beat Wall Street EPS estimates 8 times, most recently a beat result in Q3 FY2026. Magnisto tracks every Intuitive Surgical (ISRG) quarter's revenue and EPS versus consensus and grades each one Beat, Miss, In-line or Mixed at a unified ±2% threshold.
How much does Intuitive Surgical stock move after earnings?
Over its last 8 quarterly reports, Intuitive Surgical (ISRG) moved an average of ±6.3% the day after earnings — ranging from -11.2% (Q3 FY2026) to +15.0% (Q4 FY2025). The stock rose after 5 of those 8 reports and fell after 3. Heading into its next report on Oct 20, 2026, options-implied volatility is pricing in a move of roughly ±16.3% (derived). Magnisto tracks the realized post-earnings move for every Intuitive Surgical (ISRG) quarter alongside the beat/miss verdict — past moves don't predict the next one.
Who are the largest shareholders of Intuitive Surgical?
Institutions hold about 147.0% of Intuitive Surgical's (ISRG) shares outstanding as of the 2026-06-30 13F quarter. Its largest institutional holders include Blackrock, INC. (8.5%), Vanguard Capital Management LLC (6.5%), State Street Corp (4.5%). Magnisto lists Intuitive Surgical's (ISRG) top 13F holders with each stake size and its quarter-over-quarter change.
Are insiders buying or selling Intuitive Surgical (ISRG)?
In the most recent Form 4 filings Magnisto tracks, Intuitive Surgical (ISRG) insiders recorded 0 purchases and 12 sales — net selling. Insider transactions are one signal among many and are often routine (option exercises or scheduled 10b5-1 sales), so Magnisto shows the raw feed for you to judge.
What is the forecast for Intuitive Surgical (ISRG) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Intuitive Surgical (ISRG), anchored to the current $373.57 share price, so you can weigh the bull, base and bear cases for Intuitive Surgical side by side.
Is Intuitive Surgical (ISRG) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Intuitive Surgical fits your own thesis and risk profile. This is research, not investment advice.